List of Equipment Companies in Denmark - 5

We help accelerate the World's quest for sustainable food and materials The world needs new solutions to tackle the mounting sustainability challenges. Biotech offers an extraordinary potential to replace and improve many foods and materials with attractive sustainable bio-based solutions*. With the advances in technology, insight and data, the discovery of new molecules has only just begun. However, far too few promising molecule innovations have been successfully commercialized and made a true sustainable impact on the World. 21st.BIO helps you accelerate by building a competitive manufacturing foundation for your innovation - allowing you to focus on succeeding in the market and your next discovery. We partner with you on your journey to the market through: 1) Assessment of the technical potential in delivering your innovation – the expression system, the strain base, yield potential, investments required and the best way forward 2) Access to and optimization of high-performance strain platforms and production media across multiple expression systems 3) Building your scale up process and provide volumes for testing your innovations in the market 4) Providing a high quality, proven low investment way for you to manufacture in very large scale – your "fermentation cloud solution"

Axlab A/S is a Danish-owned company that since 1993 has supplied advanced equipment to pathology departments at hospitals and laboratories. Today, we deliver solutions throughout Europe and the United States. We are headquartered in Vedbæk, near Copenhagen and have a subsidiary in Sweden. The ability to understand the everyday life of the individual bioanalyst and pathologist is absolutely essential for Axlab. We have our roots in the world of the laboratory and visit the pathology departments of the hospitals as often as possible to experience the challenges of everyday life up close. And it is with this valuable knowledge as inspiration that we deliver the advanced technological solutions that are not only crucial for the laboratory’s efficiency but also ensure an optimal working environment and the highest possible quality in the analysis work. For the benefit of both staff and patients.

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

Fida Biosystems (Fidabio) offers a new proprietary technology developed for quantification and characterization of proteins and nanoparticles from 0.5 to 1,000 nm Dh, incl. antibodies, liposomes, exosomes, membrane embedded proteins et al. Based on accurate, in-solution, absolute measurements of hydrodynamic radius, the technology provides precise information about Kd, concentration, size, stoichiometry, conformational changes, oligomeric state, immunogenicity, multiple bindings etc. It is characterised by being fast (minutes), requiring very small sample amounts (ul-nl), and being exceptionally tolerant to the sample matrix, incl. plasma, serum, cell lysate, fermentation media etc. Contrary to most other procedures, the methodology is based on binding in homogenous solution; complications related to non-specific surface adsorption and challenging assay development are therefore avoided. I.e. the unique features of the FIDA technology enable characterisation and quantification in native (biorelevant) environments and in-built assay quality control and automation.

Demant is a world-leading hearing healthcare and technology group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people's hearing and health. In every aspect, from providing hearing care to delivering hearing aids, hearing implants and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged. And with the Group's many years of experience with audio and hearing technology, Demant has evolved into a growing business within premium audio and video solutions for enterprises and gaming. The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 20,000 employees and generates an annual revenue of more than DKK 19 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health. Listed on Nasdaq Copenhagen stock exchange, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, Oticon Medical, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx, Audioscan and EPOS. The William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks. If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice#some